ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
The SGLT2 inhibitor empagliflozin promotes increased fatty acid oxidation in skeletal muscle cells.
Stanislava Stevanovic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it